Aging of the CD4 t cell compartment

Open Longevity Science

Volumn 6, Issue , 2012, Pages 83-91

  Lefebvre, Julie S ^a   Haynes, Laura ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

Age associated defects; CD4 + T cells

Indexed keywords

APOPTOSIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL AGING; CELL COMPARTMENTALIZATION; CELLULAR IMMUNITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 84863922149     PISSN: None     EISSN: 1876326X     Source Type: Journal    
DOI: 10.2174/1876326X01206010083     Document Type: Article

References (100)

1. Administration on Aging [homepage on the internet]. Washington, DC: Department of Health & Human Services.[updated 2010 June 30; cited 2011 Aug 1];Available from: http://www.aoa.gov/AoARoot/Aging_Statistics/index.aspx
2. Cabre M. Pneumonia in the elderly. Curr Opin Pulm Med 2009;15:223-9.
3. Dao CN, Kamimoto L, Nowell M, Reingold A, Gershman K, Meek J, et al. Adult hospitalizations for laboratory-positive influenza dur-ing the 2005-2006 through 2007-2008 seasons in the United States. J Infect Dis 2010;202:881-8.
4. Toapanta FR, Ross TM. Impaired immune responses in the lungs of aged mice following influenza infection. Respir Res 2009;10:112.
5. McElhaney JE. Influenza vaccine responses in older adults. Ageing Res Rev 2011;10:379-88.
6. Chen WH, Kozlovsky BF, Effros RB, Grubeck-Loebenstein B, Edelman R, Sztein MB. Vaccination in the elderly: an immunolog-ical perspective. Trends Immunol 2009;30:351-9.
7. Simioni PU, Costa EH, Tamashiro WM. Aging reduces the primary humoral response and the in vitro cytokine production in mice. Braz J Med Biol Res 2007;40:1111-20.
8. Gahring LC, Weigle WO. The effect of aging on the induction of humoral and cellular immunity and tolerance in two long-lived mouse strains. Cell Immunol 1990;128:142-51.
9. Yang X, Stedra J, Cerny J. Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice. J Exp Med 1996;183:959-70.
10. Zheng B, Han S, Takahashi Y, Kelsoe G. Immunosenescence and germinal center reaction. Immunol Rev 1997;160:63-77.
11. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 1996;14:591-617.
12. Miller RA. Age-associated decline in precursor frequency for different T cell-mediated reactions, with preservation of helper or cytotoxic effect per precursor cell. J Immunol 1984;132:63-8.
13. Kovaiou RD, Weiskirchner I, Keller M, Pfister G, Cioca DP, Grubeck-Loebenstein B. Age-related differences in phenotype and function of CD4+ T cells are due to a phenotypic shift from naive to memory effector CD4+ T cells. Int Immunol 2005;17:1359-66.
14. Lerner A, Yamada T, Miller RA. Pgp-1hi T lymphocytes accumu-late with age in mice and respond poorly to concanavalin A. Eur J Immunol 1989;19:977-82.
15. Jackola DR, Ruger JK, Miller RA. Age-associated changes in human T cell phenotype and function. Aging (Milano) 1994;6:25-34.
16. Hakim FT, Memon SA, Cepeda R, Jones EC, Chow CK, Kasten-Sportes C, et al. Age-dependent incidence, time course, and conse-quences of thymic renewal in adults. J Clin Invest 2005;115:930-9.
17. Dion ML, Sekaly RP, Cheynier R. Estimating thymic function through quantification of T-cell receptor excision circles. Methods Mol Biol 2007;380:197-213.
18. Sempowski GD, Hale LP, Sundy JS, Massey JM, Koup RA, Douek DC, et al. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol 2000;164:2180-7.
19. Scollay RG, Butcher EC, Weissman IL. Thymus cell migration. Quantitative aspects of cellular traffic from the thymus to the pe-riphery in mice. Eur J Immunol 1980;10:210-8.
20. Boyman O, Letourneau S, Krieg C, Sprent J. Homeostatic prolifer-ation and survival of naive and memory T cells. Eur J Immunol 2009;39:2088-94.
21. Sprent J, Schaefer M, Hurd M, Surh CD, Ron Y. Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype. J Exp Med 1991;174:717-28.
22. Tough DF, Sprent J. Turnover of naive-and memory-phenotype T cells. J Exp Med 1994;179:1127-35.
23. Surh CD, Sprent J. Homeostasis of naive and memory T cells. Immunity 2008;29:848-62.
24. Timm JA, Thoman ML. Maturation of CD4+ lymphocytes in the aged microenvironment results in a memory-enriched population. J Immunol 1999;162:711-7.
25. Soares MV, Borthwick NJ, Maini MK, Janossy G, Salmon M, Akbar AN. IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire. J Immunol 1998;161:5909-17.
26. Kilpatrick RD, Rickabaugh T, Hultin LE, Hultin P, Hausner MA, Detels R, et al. Homeostasis of the naive CD4+ T cell compartment during aging. J Immunol 2008;180:1499-507.
27. Sharma S, Dominguez AL, Lustgarten J. High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. J Immunol 2006;177:8348-55.
28. Zhao L, Sun L, Wang H, Ma H, Liu G, Zhao Y. Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice. J Leukoc Biol 2007;81:1386-94.
29. Lages CS, Suffia I, Velilla PA, Huang B, Warshaw G, Hildeman DA, et al. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol 2008;181:1835-48.
30. Chiu BC, Stolberg VR, Zhang H, Chensue SW. Increased Foxp3(+) Treg cell activity reduces dendritic cell co-stimulatory molecule expression in aged mice. Mech Ageing Dev 2007;128:618-27.
31. Rosenkranz D, Weyer S, Tolosa E, Gaenslen A, Berg D, Leyhe T, et al. Higher frequency of regulatory T cells in the elderly and in-creased suppressive activity in neurodegeneration. J Neuroimmunol 2007;188:117-27.
32. Kozlowska E, Biernacka M, Ciechomska M, Drela N. Age-related changes in the occurrence and characteristics of thymic CD4(+) CD25(+) T cells in mice. Immunology 2007;122:445-53.
33. Hwang KA, Kim HR, Kang I. Aging and human CD4(+) regulatory T cells. Mech Ageing Dev 2009;130:509-17.
34. Workman CJ, Szymczak-Workman AL, Collison LW, Pillai MR, Vignali DA. The development and function of regulatory T cells. Cell Mol Life Sci 2009;66:2603-22.
35. Eaton SM, Burns EM, Kusser K, Randall TD, Haynes L. Age-related defects in CD4 T cell cognate helper function lead to reduc-tions in humoral responses. J Exp Med 2004;200:1613-22.
36. Tsukamoto H, Clise-Dwyer K, Huston GE, Duso DK, Buck AL, Johnson LL, et al. Age-associated increase in lifespan of naive CD4 T cells contributes to T-cell homeostasis but facilitates develop-ment of functional defects. Proc Natl Acad Sci U S A 2009;106:18333-8.
37. Tsukamoto H, Huston GE, Dibble J, Duso DK, Swain SL. Bim dictates naive CD4 T cell lifespan and the development of age-associated functional defects. J Immunol 2010;185:4535-44.
38. Haynes L, Eaton SM. The effect of age on the cognate function of CD4+ T cells. Immunol Rev 2005;205:220-8.
39. Haynes L, Eaton SM, Burns EM, Randall TD, Swain SL. Newly generated CD4 T cells in aged animals do not exhibit age-related defects in response to antigen. J Exp Med 2005;201:845-51.
40. Rea IM, Stewart M, Campbell P, Alexander HD, Crockard AD, Morris TC. Changes in lymphocyte subsets, interleukin 2, and sol-uble interleukin 2 receptor in old and very old age. Gerontology 1996;42:69-78.
41. Bachmann MF, Oxenius A. Interleukin 2: from immunostimulation to immunoregulation and back again. EMBO Rep 2007;8:1142-8.
42. Haynes L, Linton PJ, Eaton SM, Tonkonogy SL, Swain SL. Inter-leukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med 1999;190:1013-24.
43. Beckman I, Dimopoulos K, Xu XN, Ahern M, Bradley J. Age-related changes in the activation requirements of human CD4+ T-cell subsets. Cell Immunol 1991;132:17-25.
44. Bruunsgaard H, Pedersen AN, Schroll M, Skinhoj P, Pedersen BK. Proliferative responses of blood mononuclear cells (BMNC) in a cohort of elderly humans: role of lymphocyte phenotype and cyto-kine production. Clin Exp Immunol 2000;119:433-40.
45. Larbi A, Pawelec G, Wong SC, Goldeck D, Tai JJ, Fulop T. Impact of age on T cell signaling: a general defect or specific alterations? Ageing Res Rev 2011;10:370-8.
46. Garcia GG, Miller RA. Single-cell analyses reveal two defects in peptide-specific activation of naive T cells from aged mice. J Im-munol 2001;166:3151-7.
47. Tamir A, Eisenbraun MD, Garcia GG, Miller RA. Age-dependent alterations in the assembly of signal transduction complexes at the site of T cell/APC interaction. J Immunol 2000;165:1243-51.
48. Whisler RL, Chen M, Liu B, Newhouse YG. Age-related impair-ments in TCR/CD3 activation of ZAP-70 are associated with re-duced tyrosine phosphorylations of zeta-chains and p59fyn/p56lck in human T cells. Mech Ageing Dev 1999;111:49-66.
49. Garcia GG, Miller RA. Age-related defects in the cytoskeleton signaling pathways of CD4 T cells. Ageing Res Rev 2011;10:26-34.
50. Kirk CJ, Miller RA. Analysis of Raf-1 activation in response to TCR activation and costimulation in murine T-lymphocytes: effect of age. Cell Immunol 1998;190:33-42.
51. Whisler RL, Beiqing L, Chen M. Age-related decreases in IL-2 production by human T cells are associated with impaired activa-tion of nuclear transcriptional factors AP-1 and NF-AT. Cell Immunol 1996;169:185-95.
52. Whisler RL, Chen M, Beiqing L, Carle KW. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging. Cell Immunol 1997;175:41-50.
53. Kurtulus S, Tripathi P, Opferman JT, Hildeman DA. Contracting the 'mus cells'--does down-sizing suit us for diving into the memory pool? Immunol Rev 2010;236:54-67.
54. Aggarwal S, Gollapudi S, Gupta S. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J Immunol 1999;162: 2154-61.
55. Aggarwal S, Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J Immunol 1998;160:1627-37.
56. Mucida D, Cheroutre H. The many face-lifts of CD4 T helper cells. Adv Immunol 2010;107:139-52.
57. Haynes L, Eaton SM, Swain SL. The defects in effector generation associated with aging can be reversed by addition of IL-2 but not other related gamma(c)-receptor binding cytokines. Vaccine 2000;18:1649-53.
58. Sakata-Kaneko S, Wakatsuki Y, Matsunaga Y, Usui T, Kita T. Altered Th1/Th2 commitment in human CD4+ T cells with ageing. Clin Exp Immunol 2000;120:267-73.
59. Maue AC, Eaton SM, Lanthier PA, Sweet KB, Blumerman SL, Haynes L. Proinflammatory adjuvants enhance the cognate helper activity of aged CD4 T cells. J Immunol 2009;182:6129-35.
60. Huang MC, Liao JJ, Bonasera S, Longo DL, Goetzl EJ. Nuclear factor-kappaB-dependent reversal of aging-induced alterations in T cell cytokines. FASEB J 2008;22:2142-50.
61. Ouyang X, Yang Z, Zhang R, Arnaboldi P, Lu G, Li Q, et al. Potentiation of Th17 cytokines in aging process contributes to the development of colitis. Cell Immunol 2011;266:208-17.
62. Lee JS, Lee WW, Kim SH, Kang Y, Lee N, Shin MS, et al. Age-associated alteration in naive and memory Th17 cell response in humans. Clin Immunol 2011;140:84-91.
63. Tesar BM, Du W, Shirali AC, Walker WE, Shen H, Goldstein DR. Aging augments IL-17 T-cell alloimmune responses. Am J Trans-plant 2009;9:54-63.
64. Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, Sexton GJ, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med 2003;9:1131-7.
65. Gerlach C, van Heijst JW, Schumacher TN. The descent of memory T cells. Ann N Y Acad Sci 2011;1217:139-53.
66. Kang I, Hong MS, Nolasco H, Park SH, Dan JM, Choi JY, et al. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol 2004;173:673-81.
67. Mattoo H, Faulkner M, Kandpal U, Das R, Lewis V, George A, et al. Naive CD4 T cells from aged mice show enhanced death upon primary activation. Int Immunol 2009;21:1277-89.
68. Kim C, Williams MA. Nature and nurture: T-cell receptor-dependent and T-cell receptor-independent differentiation cues in the selection of the memory T-cell pool. Immunology 2010;131:310-7.
69. Haynes L, Eaton SM, Burns EM, Randall TD, Swain SL. CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci U S A 2003;100:15053-8.
70. Eaton SM, Maue AC, Swain SL, Haynes L. Bone marrow precur-sor cells from aged mice generate CD4 T cells that function well in primary and memory responses. J Immunol 2008;181:4825-31.
71. Hale TJ, Richardson BC, Sweet LI, McElligott DL, Riggs JE, Chu EB, et al. Age-related changes in mature CD4+ T cells: cell cycle analysis. Cell Immunol 2002;220:51-62.
72. Channappanavar R, Twardy BS, Krishna P, Suvas S. Advancing age leads to predominance of inhibitory receptor expressing CD4 T cells. Mech Ageing Dev 2009;130:709-12.
73. Shimada Y, Hayashi M, Nagasaka Y, Ohno-Iwashita Y, Inomata M. Age-associated up-regulation of a negative co-stimulatory re-ceptor PD-1 in mouse CD4+ T cells. Exp Gerontol 2009;44:517-22.
74. Lages CS, Lewkowich I, Sproles A, Wills-Karp M, Chougnet C. Partial restoration of T-cell function in aged mice by in vitro block-ade of the PD-1/ PD-L1 pathway. Aging Cell 2010;9:785-98.
75. Mittler JN, Lee WT. Antigen-specific CD4 T cell clonal expansion and differentiation in the aged lymphoid microenvironment. II. The memory T cell response is diminished. Mech Ageing Dev 2004;125:59-68.
76. Aggarwal S, Tsuruo T, Gupta S. Altered expression and function of P-glycoprotein (170 kDa), encoded by the MDR 1 gene, in T cell subsets from aging humans. J Clin Immunol 1997;17:448-54.
77. Bining N, Miller RA. Cytokine production by subsets of CD4 memory T cells differing in P-glycoprotein expression: effects of aging. J Gerontol A Biol Sci Med Sci 1997;52:B137-B145.
78. Witkowski JM, Miller RA. Increased function of P-glycoprotein in T lymphocyte subsets of aging mice. J Immunol 1993;150:1296-306.
79. Machado CG, Calado RT, Garcia AB, Falcao RP. Age-related changes of the multidrug resistance P-glycoprotein function in normal human peripheral blood T lymphocytes. Braz J Med Biol Res 2003;36:1653-7.
80. Pilarski LM, Paine D, McElhaney JE, Cass CE, Belch AR. Multi-drug transporter P-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: modulation with dif-ferentiation stage and during aging. Am J Hematol 1995;49:323-35.
81. Eisenbraun MD, Miller RA. mdr1a-encoded P-glycoprotein is not required for peripheral T cell proliferation, cytokine release, or cy-totoxic effector function in mice. J Immunol 1999;163:2621-7.
82. Witkowski JM, Miller RA. Calcium signal abnormalities in murine T lymphocytes that express the multidrug transporter P-glycoprotein. Mech Ageing Dev 1999;107:165-80.
83. Witkowski JM, Li SP, Gorgas G, Miller RA. Extrusion of the P glycoprotein substrate rhodamine-123 distinguishes CD4 memory T cell subsets that differ in IL-2-driven IL-4 production. J Immunol 1994;153:658-65.
84. Eisenbraun MD, Tamir A, Miller RA. Altered composition of the immunological synapse in an anergic, age-dependent memory T cell subset. J Immunol 2000;164:6105-12.
85. Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010;11:7-13.
86. Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 2009;182:8071-9.
87. Dejaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M. Imbal-ance of regulatory T cells in human autoimmune diseases. Immu-nology 2006;117:289-300.
88. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting in-terleukin 2 production. J Exp Med 1998;188:287-96.
89. Tsaknaridis L, Spencer L, Culbertson N, Hicks K, LaTocha D, Chou YK, et al. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 2003;74:296-308.
90. Gregg R, Smith CM, Clark FJ, Dunnion D, Khan N, Chakraverty R, et al. The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age. Clin Exp Immunol 2005;140:540-6.
91. Nishioka T, Shimizu J, Iida R, Yamazaki S, Sakaguchi S. CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice. J Immunol 2006;176:6586-93.
92. Shimizu J, Moriizumi E. CD4+CD25-T cells in aged mice are hyporesponsive and exhibit suppressive activity. J Immunol 2003;170:1675-82.
93. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996;184:387-96.
94. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001;167:1245-53.
95. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-61.
96. Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003;4:337-42.
97. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003;4:330-6.
98. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005;22:329-41.
99. Probst-Kepper M, Geffers R, Kroger A, Viegas N, Erck C, Hecht HJ, et al. GARP: a key receptor controlling FOXP3 in human regu-latory T cells. J Cell Mol Med 2009;13:3343-57.
100. Han GM, Zhao B, Jeyaseelan S, Feng JM. Age-associated parallel increase of Foxp3(+)CD4(+) regulatory and CD44(+)CD4(+) memory T cells in SJL/J mice. Cell Immunol 2009;258:188-96.